Cite
HARVARD Citation
Pourabdollah, M. et al. (2016). High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide. Journal of hematology & oncology. 9 (1), pp. 1-4. [Online].